Advertisement

Contraception and Infertility

  • Alfonso Araujo Massaguer
  • Paula Beatriz Fettback
  • Vamberto Oliveira de Azevedo Maia Filho
  • Sérgio Pereira Gonçalves
  • Cassiana Rosa Galvão Giribela
Chapter

Abstract

The use of contraception by women is common. Birth control pills and other hormonal methods are used by millions of women around the world. The need to evaluate the influence of these methods on the genesis of the breast tumor is clear.

Recommended Reading

  1. 1.
    Bhupathiraju SN, et al. Exogenous hormone use: oral contraceptives, postmenopausal hormone therapy, and health outcomes in the Nurses’ Health Study. Am J Public Health. 2016;106(9):1631–7.CrossRefGoogle Scholar
  2. 2.
    Brohet RM, Goldgar DE, Easton DF, et al. Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating Group. J Clin Oncol. 2007;25:3831.CrossRefGoogle Scholar
  3. 3.
    Gierisch JM, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev. 2013;22(11):1931–43.CrossRefGoogle Scholar
  4. 4.
    Hankinson SE, Colditz GA, Manson JE, et al. A prospective study of oral contraceptive use and risk of breast cancer. Cancer Causes Control. 1997;8:65.CrossRefGoogle Scholar
  5. 5.
    Hannaford PC, Selvaraj S, Elliott AM, et al. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner’s oral contraception study. BMJ. 2007;335:651.CrossRefGoogle Scholar
  6. 6.
    Ismail-Khan R, Minton S, Cox C, Sims I, Lacevic M, et al. Preservation of ovarian function in young women treated with neoadjuvant chemotherapy for breast cancer: a randomized trial using the GnRH agonist (triptorelin) during chemotherapy. J Clin Oncol. 2008;26:524.CrossRefGoogle Scholar
  7. 7.
    Jain JK, Paulson RJ. Oocyte cryopreservation. Fertil Steril. 2006;86(Suppl 4):1037.CrossRefGoogle Scholar
  8. 8.
    Kosasa TS, McNamee PI, Morton C, Huang TT. Pregnancy rates after transfer of cryopreserved blastocysts cultured in a sequential media. Am J Obstet Gynecol. 2005;192:2035.CrossRefGoogle Scholar
  9. 9.
    Lambertini M, et al. Controversies about fertility and pregnancy issues in young breast cancer patients: current state of the art. Curr Opin Oncol. 2017;29(4):243–52.CrossRefGoogle Scholar
  10. 10.
    Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med. 2002;346:2025.CrossRefGoogle Scholar
  11. 11.
    Massarotti C, et al. State of the art on oocyte cryopreservation in female cancer patients: a critical review of the literature. Cancer Treat Rev. 2017;57:50–7. Studies evaluating the efficiency of egg freezing. INTERPRETATION: Freezing of eggs is a promising technique, but results are still lower than results on embryo freezing. CrossRefGoogle Scholar
  12. 12.
    Moorman PG, et al. Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol. 2013;31(33):4188–98. Four studies (cohort, control case and a meta-analysis) that evaluated BRCA1 or 2 mutation carriers and the use of oral contraceptives are discussed here. INTERPRETATION: In BRCA1 or 2 mutation carriers, oral contraception may increase the risk of breast cancer. CrossRefGoogle Scholar
  13. 13.
    Narod SA, Dube MP, Klijn J, et al. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst. 2002;94:1773.CrossRefGoogle Scholar
  14. 14.
    Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol. 2005;23:3858.CrossRefGoogle Scholar
  15. 15.
    Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23:4347. Studies evaluating the efficacy of letrozole and tamoxifen for ovarian stimulation. INTERPRETATION: Letrozole and tamoxifen are valid options for ovarian stimulation and embryo freezing. CrossRefGoogle Scholar
  16. 16.
    Oktay K, Cil AP, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril. 2006;86:70.CrossRefGoogle Scholar
  17. 17.
    Samson M, Porter N, Orekoya O, Hebert JR, Adams SA, Bennett CL, Steck SE. Progestin and breast cancer risk: a systematic review. Breast Cancer Res Treat. 2016;155(1):3–12.  https://doi.org/10.1007/s10549-015-3663-1. Epub 2015 Dec. The first three studies are epidemiological studies. The first one (Hannaford et al.) with nearly 50,000 women followed on average for 24 years. The incidence of breast cancer was similar in users and non-users of pills. The fifth indicates otherwise. The fourth, sixth and seventh ones are more recent meta-analyses. The fourth one concludes that oral contraceptives are not related to breast tumor deaths. The sixth study assesses the risk of oral contraceptives and concludes a small increase in risk. The seventh one indicates that progesterone-only formulations do not increase the risk of breast tumor. INTERPRETATION: This subject is still controversial, but it is known that combined oral contraceptives could increase the risk of breast tumor. CrossRefPubMedGoogle Scholar
  18. 18.
    Taylan E, Oktay KH. Current state and controversies in fertility preservation in women with breast cancer. World J Clin Oncol. 2017;8(3):241–8. Randomized study evaluating the effect of GnRH agonist on preservation of fertility in patients submitted to neoadjuvant chemotherapy for breast tumor, and review on the subject. INTERPRETATION: Ovary blockade with GnRH agonist has no proven benefit for preservation of fertility in patients undergoing chemotherapy. CrossRefGoogle Scholar
  19. 19.
    Ursin G, Henderson BE, Haile RW, et al. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women? Cancer Res. 1997;57:3678.PubMedGoogle Scholar
  20. 20.
    Veeck LL, Bodine R, Clarke RN, et al. High pregnancy rates can be achieved after freezing and thawing human blastocysts. Fertil Steril. 2004;82:1418. Pieces of work comparing the rate of implantation of fresh and frozen embryos and revision. INTERPRETATION: Embryo freezing methods are effective at implantation rates similar to unfrozen embryos. CrossRefGoogle Scholar
  21. 21.
    Zhong GC, Cheng JH, Xu XL, Wang K. Meta-analysis of oral contraceptive use and risks of all-cause and cause-specific death. Int J Gynaecol Obstet. 2015;131(3):228–33.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Alfonso Araujo Massaguer
    • 1
  • Paula Beatriz Fettback
    • 1
  • Vamberto Oliveira de Azevedo Maia Filho
    • 1
  • Sérgio Pereira Gonçalves
    • 2
  • Cassiana Rosa Galvão Giribela
    • 2
  1. 1.Clínica MãeSão PauloBrazil
  2. 2.GynecologyUniversity of São PauloSão PauloBrazil

Personalised recommendations